Streetbeat News

Regulatory

DNA

Ginkgo Bioworks' stock is up following three positive announcements: a Ginkgo-led team received funding from the U.S. Department of Energy (DOE) for algal crop protection solutions, Greenlab formed a new partnership with Ginkgo for PFAS-related work, and Ginkgo's subsidiary FGen AG secured funding through the European Innovation Council's (EIC) Pathfinder Challenge program.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 5:10 pm

TEF

The Spanish government has directed SEPI, a state holding company, to purchase up to a 10% stake in telecommunications company Telefonica.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 5:09 pm

ETAO

ETAO International's stock is trading lower following the announcement of a Nasdaq delisting determination.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 5:03 pm

MCOM

Shares of micromobility.com (MCOM) are trading lower following the announcement of a Nasdaq delisting notice. The company also postponed its special meeting of stockholders and withdrew its request for a reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:59 pm

INBS

Intelligent Bio Solutions' stock is up following the announcement that its Intelligent Fingerprinting Drug Screening Solution has received accreditation from the National Association of Testing Authorities.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:56 pm

SPY

VGK

Ukraine's President Zelenskiy expressed uncertainty about the end of the war, emphasizing the need for resilience to hasten its conclusion. He is confident in the continued financial support from the U.S. and Europe, highlighting Ukraine's special relationship with these regions.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:29 pm

SPY

VGK

Ukrainian President Zelenskiy has stated that the military requires an additional 450,000-500,000 personnel for mobilization. He expressed confidence in continued U.S. support for Ukraine.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:24 pm

MCOM

Micromobility.com Inc. (NASDAQ:MCOM) shares plummeted by 49.6% after receiving a notice from Nasdaq about an impending suspension due to failure to meet minimum bid price and equity requirements. The company postponed a shareholder meeting to reevaluate its strategy and is considering delisting in favor of trading on OTC markets to reduce compliance costs, despite potential negative effects on stock liquidity and price.

Portfolio Pulse from Henry Khederian

December 19, 2023 | 4:14 pm

NVO

Novo Nordisk A/S (NYSE:NVO) has collaborated with IndiaMART to remove unauthorized listings of its weight-loss drug Wegovy in India. IndiaMART took action after discussions with Novo Nordisk, who is the sole patent holder of semaglutide, the active ingredient in Wegovy and diabetes medication Ozempic. The company's legal team in India is working to establish a framework to notify and remove counterfeit listings to curb illegal sales. Despite the challenges in tracing illegal sellers, Novo Nordisk regularly monitors and engages with platforms to prevent unauthorized sales. IndiaMART has been listed on a U.S. government agency's 'Notorious Markets' list for 2022, indicating ongoing issues with counterfeit goods. NVO shares saw a 1.46% increase to $100.43.

Portfolio Pulse from Vandana Singh

December 19, 2023 | 3:53 pm

PBLA

Panbela Therapeutics Inc (NASDAQ:PBLA) stock surged 62% to $1.64 after announcing FDA approval of eflornithine, a drug they divested to US WorldMeds, for high-risk neuroblastoma patients. The approval marks the first for a polyamine targeted therapy in cancer, with Panbela potentially receiving up to $9.5 million based on milestones. The company's executives are optimistic about the drug's impact on neuroblastoma and other cancers. PBLA's 52-week range is $0.45 to $225.71.

Portfolio Pulse from Henry Khederian

December 19, 2023 | 3:40 pm